Navigation Links
StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.

ProductsStemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item StemSep Hu-Mu Chimera Starter Kit, Kit
Price 
Description This complete kit contains enough separation reagents to perform separations from a total of 5 x 108 cells, and includes the StemSep red magnet and all the necessary reagents and buffers for the specific cell type to be enriched, including the StemSep red magnet.
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. StemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.
2. StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
3. StemSep anti-Hu TCR alpha beta, 200 uL from StemCell Technologies, Inc.
4. StemSep Anti-Hu HLA-DR Tetramer, 100 uL from StemCell Technologies, Inc.
5. StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
6. StemSep Rat CD4+ T Cells, 10 mL from StemCell Technologies, Inc.
7. StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
8. StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
9. StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
10. StemSep Anti-Phycoertherin TAC, 2 mL from StemCell Technologies, Inc.
11. Viral CCI, Unconjugated, Fc Chimera from R&D Systems
Breaking Biology Technology:Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3